| 1 |
32944399 | An ATF24 peptide-functionalized β-elemene-nanostructured lipid carrier combined with cisplatin for bladder cancer treatment. | 2020 Aug 15 |
1 |
| 2 |
29245943 | Saikosaponin-d, a calcium mobilizing agent, sensitizes chemoresistant ovarian cancer cells to cisplatin-induced apoptosis by facilitating mitochondrial fission and G2/M arrest. | 2017 Nov 21 |
2 |
| 3 |
27246979 | Cdc6 contributes to cisplatin-resistance by activation of ATR-Chk1 pathway in bladder cancer cells. | 2016 Jun 28 |
1 |
| 4 |
27322682 | Downregulation of vimentin expression increased drug resistance in ovarian cancer cells. | 2016 Jul 19 |
1 |
| 5 |
27552991 | Myelodysplasia-associated mutations in serine/arginine-rich splicing factor SRSF2 lead to alternative splicing of CDC25C. | 2016 Aug 23 |
1 |
| 6 |
25625243 | Cisplatin resistance in human lung cancer cells is linked with dysregulation of cell cycle associated proteins. | 2015 Mar 1 |
2 |
| 7 |
26396928 | Synergistic effect of allyl isothiocyanate (AITC) on cisplatin efficacy in vitro and in vivo. | 2015 |
1 |
| 8 |
23397083 | Sensitization of lung cancer cells to cisplatin by β-elemene is mediated through blockade of cell cycle progression: antitumor efficacies of β-elemene and its synthetic analogs. | 2013 Mar |
1 |
| 9 |
22871320 | Genotoxic stress modulates CDC25C phosphatase alternative splicing in human breast cancer cell lines. | 2012 Oct |
1 |
| 10 |
20623183 | Estrogen receptor beta decreases survival of p53-defective cancer cells after DNA damage by impairing G₂/M checkpoint signaling. | 2011 Jun |
1 |
| 11 |
20655883 | Polo-like kinase1 (Plk1) knockdown enhances cisplatin chemosensitivity via up-regulation of p73α in p53 mutant human epidermoid squamous carcinoma cells. | 2010 Nov 1 |
1 |
| 12 |
20700484 | NPRL2 sensitizes human non-small cell lung cancer (NSCLC) cells to cisplatin treatment by regulating key components in the DNA repair pathway. | 2010 Aug 5 |
2 |
| 13 |
15868412 | Antiproliferative effect of beta-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase. | 2005 Apr |
1 |
| 14 |
9743457 | Cisplatin-induced inhibition of p34cdc2 is abolished by 5-fluorouracil. | 1998 |
2 |